Short answer
Guardant Health, Inc. (GH) filed its Q3 2025 10-Q quarterly report on Oct 29, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $265M (up 38.5% year over year) with net income of −$93M.
Q3 2025 key financials · XBRL
- Revenue
- $265M
- +38.5% YoY · +14.3% QoQ
- Net income
- −$93M
- +13.9% YoY · +7.2% QoQ
- Operating margin
- -37.3%
- EPS (diluted)
- −$0.75
- +14.8% YoY · +6.3% QoQ
Source: XBRL data from the Guardant Health, Inc. (GH) Q3 2025 10-Q on SEC EDGAR. USD.
Guardant Health, Inc. Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No new risk factors added this quarter; no material changes since fiscal 2024 10-K filing
- Most materially updated risk: none reported, risk factors unchanged since 2024 10-K
- Compliance risk: continues to reflect prior SEC filings with no new regulatory issues disclosed
- Operational risk: no new competitive or market risk updates impacting near-term performance disclosed
- Financial risk: no changes to liquidity, debt maturity, or currency exposure risks since 2024 10-K
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Guardant Health, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.